These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32972246)

  • 1. Developing cyclic peptide-based drug candidates: an overview.
    Jin K
    Future Med Chem; 2020 Oct; 12(19):1687-1690. PubMed ID: 32972246
    [No Abstract]   [Full Text] [Related]  

  • 2. A gold mine for drug discovery: Strategies to develop cyclic peptides into therapies.
    Jing X; Jin K
    Med Res Rev; 2020 Mar; 40(2):753-810. PubMed ID: 31599007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting signal pathways triggered by cyclic peptides in cancer: Current trends and future challenges.
    Yang Y; Mao H; Chen L; Li L
    Arch Biochem Biophys; 2021 Apr; 701():108776. PubMed ID: 33515532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Cyclopeptides as Anticancer Agents in the Last 20 Years.
    Zhang JN; Xia YX; Zhang HJ
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic Peptides for the Treatment of Cancers: A Review.
    Ramadhani D; Maharani R; Gazzali AM; Muchtaridi M
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in Synthesis and Identification of Cyclic Peptides for Bioapplications.
    Ong YS; Gao L; Kalesh KA; Yu Z; Wang J; Liu C; Li Y; Sun H; Lee SS
    Curr Top Med Chem; 2017; 17(20):2302-2318. PubMed ID: 28240181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicyclic Peptides as Scaffolds for the Development of Tumor Targeting Agents.
    Loktev A; Haberkorn U; Mier W
    Curr Med Chem; 2017; 24(20):2141-2155. PubMed ID: 28302013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry. Rings of destruction.
    Ganz T
    Nature; 2001 Jul; 412(6845):392-3. PubMed ID: 11473296
    [No Abstract]   [Full Text] [Related]  

  • 9. Combinatorial modification of natural products: synthesis and in vitro analysis of derivatives of thiazole peptide antibiotic GE2270 A: A-ring modifications.
    Clough J; Chen S; Gordon EM; Hackbarth C; Lam S; Trias J; White RJ; Candiani G; Donadio S; Romanò G; Ciabatti R; Jacobs JW
    Bioorg Med Chem Lett; 2003 Oct; 13(20):3409-14. PubMed ID: 14505638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of cyclic peptides containing a thioester handle for native chemical ligation.
    van de Langemheen H; Brouwer AJ; Kemmink J; Kruijtzer JA; Liskamp RM
    J Org Chem; 2012 Nov; 77(22):10058-64. PubMed ID: 23078179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine/threonine ligation for natural cyclic peptide syntheses.
    Lee CL; Lam HY; Li X
    Nat Prod Rep; 2015 Sep; 32(9):1274-9. PubMed ID: 26023909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide Display Technologies.
    Pitt A; Nims Z
    Methods Mol Biol; 2019; 2001():285-298. PubMed ID: 31134576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical Synthesis of Bioactive Naturally Derived Cyclic Peptides Containing Ene-Like Rigidifying Motifs.
    De Leon Rodriguez LM; Williams ET; Brimble MA
    Chemistry; 2018 Dec; 24(68):17869-17880. PubMed ID: 29987917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering cyclic peptide toxins.
    Clark RJ; Craik DJ
    Methods Enzymol; 2012; 503():57-74. PubMed ID: 22230565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyclic Peptides: Types, Synthesis and Applications.
    Khazaei-Poul Y; Farhadi S; Ghani S; Ahmadizad SA; Ranjbari J
    Curr Pharm Biotechnol; 2021; 22(1):123-135. PubMed ID: 31987019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A convenient method for synthesis of cyclic peptide libraries.
    Bourne GT; Nielson JL; Coughlan JF; Darwen P; Campitelli MR; Horton DA; Rhümann A; Love SG; Tran TT; Smythe ML
    Methods Mol Biol; 2005; 298():151-65. PubMed ID: 16044546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Round and round we go: cyclic peptides in disease.
    Katsara M; Tselios T; Deraos S; Deraos G; Matsoukas MT; Lazoura E; Matsoukas J; Apostolopoulos V
    Curr Med Chem; 2006; 13(19):2221-32. PubMed ID: 16918350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of a cyclic double mutant peptide (cyclo(87-99)[A91,A96]MBP87-99) induces altered responses in mice after conjugation to mannan: implications in the immunotherapy of multiple sclerosis.
    Katsara M; Deraos G; Tselios T; Matsoukas MT; Friligou I; Matsoukas J; Apostolopoulos V
    J Med Chem; 2009 Jan; 52(1):214-8. PubMed ID: 19072222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial Overview.
    Craik DJ; Henriques ST
    Curr Opin Chem Biol; 2017 Jun; 38():iv-vi. PubMed ID: 28619206
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclic peptides as potential therapeutic agents for skin disorders.
    Namjoshi S; Benson HA
    Biopolymers; 2010; 94(5):673-80. PubMed ID: 20564043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.